Barlow Carrolee Insider Trades

Insider Trading History

Track insider trading activity for Barlow Carrolee. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $0 0 shares
Last Trade
Feb 24, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$239k 4,475 shares
$53.30
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $1.21M 27,045 shares
Last Trade
Feb 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$239k 4,475 shares
$53.30
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $222k 4,977 shares
Last Trade
Feb 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$400k 7,966 shares
$50.20
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $0 0 shares
Last Trade
Feb 22, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$177k 5,369 shares
$33.05
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $1.01M 22,570 shares
Last Trade
Feb 22, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$177k 5,369 shares
$33.05
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $326k 7,296 shares
Last Trade
Feb 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$245k 7,296 shares
$33.52
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $0 0 shares
Last Trade
Feb 23, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$113k 3,886 shares
$29.06
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $769k 17,201 shares
Last Trade
Feb 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$113k 3,886 shares
$29.06
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $369k 8,252 shares
Last Trade
Feb 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$231k 8,252 shares
$27.94
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $281k 6,293 shares
Last Trade
Feb 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$243k 6,293 shares
$38.60
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $0 0 shares
Last Trade
Feb 22, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$150k 3,882 shares
$38.57
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $595k 13,315 shares
Last Trade
Feb 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 3,882 shares
$38.57
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $306k 6,847 shares
Last Trade
Feb 22, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$220k 6,847 shares
$32.20
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $0 0 shares
Last Trade
Feb 19, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$139k 4,222 shares
$32.90
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $422k 9,433 shares
Last Trade
Feb 19, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$139k 4,222 shares
$32.90
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $329k 7,365 shares
Last Trade
Feb 19, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$218k 7,365 shares
$29.61
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $416k 9,305 shares
Last Trade
Feb 21, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$348k 14,516 shares
$23.99
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $555k 12,427 shares
Last Trade
Feb 22, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$457k 12,427 shares
$36.75
$44.70
Supernus Pharmaceuticals
Supernus Pharmaceuticals SUPN
Director
Holding Value $457k 10,213 shares
Last Trade
Jun 27, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$594k 10,213 shares
$58.15
$44.70

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up